Safety and Tolerability of NN9068 in Healthy Male Volunteers
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this clinical trial is to investigate the
safety, tolerability, level of drug exposure and effect of NN9068.
The trial participants will be randomised to 4 different treatments in trial, receiving trial
products in a pre-defined order.